Navigation Links
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
Date:4/21/2009

that of nocturia which may result from other conditions such as overactive bladder.

About VA111913 and dysmenorrhoea:

VA111913 is an oral small molecule drug candidate in Phase I clinical development for prevention and treatment of dysmenorrhoea, a condition characterized by abnormal contractions of the uterus during menstruation causing severe pain. VA111913 acts by blocking vasopressin 1a receptors in smooth muscle in the uterus wall, which in response to elevated vasopressin levels leads to dysmenorrhoea. VA111913 has demonstrated in preclinical trials it can normalise smooth muscle contraction thereby offering the potential for it to be the first licensed drug that directly targets the cause of this condition in the uterus.

A Phase I trial with VA111913 is underway and expected to report during H1 2009, with Phase II proof of concept studies expected to start in H2 2009, involving up to 150 patients and completing in H2 2010.

Dysmenorrhoea affects a large number of women for whom there are currently no targeted therapies; treatments that are in common use however include over-the-counter painkillers (e.g. naproxen or ibuprofen) or oral contraceptives used 'off-label'. It is estimated that the market opportunity for a targeted drug for the prophylaxis and treatment of dysmenorrhoea is approximately US$1 billion per year.

    Contact details:


    Vantia Therapeutics

    Dr Jim Phillips, CEO              +44(0)238-076-3433
    ir@vantiatherapeutics.com         +44(0)7515-397176


    Citigate Dewe Rogerson
    Chris Gardner / Mark Swallow / Helena Galilee
    +44(0)207-638-9571
    chris.gardner@citigatedr.co.uk / mark.swallow@citigatedr.co.uk /
    helena.galilee@citigatedr.c
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Escape Alert, LLC . filed international patents for ... owners if their pet has escaped and enable them to track ... the pet’s body. This is the first implantable microchip with ... around for many years, they are passive until read by scanners, ... pet’s location or alert the owner that the pet has escaped. ...
(Date:9/16/2014)... Washington, USA (PRWEB) September 16, 2014 ... to create the features that we desire in optical ... Center at Montana State University. “As we explore surfaces ... Some of those lessons were presented in San Diego ... of Light: Light in Nature ” chaired by Shaw ...
(Date:9/16/2014)... From cell phones to cars and flashlights, ... Scientists and technology companies constantly are seeking ways ... the first time using a water-based solution, researchers ... long-lasting and more efficient nuclear battery that could ... reliable energy source in automobiles and also in ...
(Date:9/16/2014)... CIRTEC Medical Systems’ Board of Directors ... of CIRTEC. , “I am delighted to be ... noted Brian Highley. “The company has made great strides ... growth over the past two years. The goal now ... and expand the services Cirtec offers its medical device ...
Breaking Biology Technology:Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 2Implantable Microchip for Pets with GPS Tracking - Patent Filed by Escape Alert, LLC. 3Nature’s designs inspire research into new light-based technologies 2Nature’s designs inspire research into new light-based technologies 3Nature’s designs inspire research into new light-based technologies 4Nature’s designs inspire research into new light-based technologies 5
... June 5 NxStage Medical, Inc.,(Nasdaq: NXTM ), ... Jeffrey H. Burbank, Chief Executive Officer, and,Robert S. Brown, ... 28th Annual Growth Stock Conference on June 18, 2008 ... investor presentation is scheduled for Wednesday, June 18th,at 3:10 ...
... Cardiac Science,Corporation (Nasdaq: CSCX ), ... rehabilitation, and informatics products, announced today,that it ... & Company Biotechnology,and Medical Technology Conference at ... vice president and chief financial officer, will ...
... Gene Control, Trait Stacking in ... Commercial Crop ... LLC and Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced,today ... Research and Commercial License Agreement. These milestones represent,the successful application ...
Cached Biology Technology:NxStage Medical to Present at William Blair Growth Stock Conference 2Cardiac Science to Present at Needham Biotechnology & Medical Technology Conference 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
(Date:9/16/2014)... school year, a new football season and another commercial ... SpaceX,s Dragon spacecraft is scheduled to blast off to ... of the company,s fourth contracted mission to the complex. ... suite of research investigations sponsored by the Center for ... role of managing the U.S. National Laboratory on the ...
(Date:9/16/2014)... its Government could face an uphill challenge in persuading ... revealed. , The University of Nottingham Shale Gas Survey ... in the UK since March 2012 and has shown ... least supportive of fracking. , Professor Sarah O,Hara, who ... said: "The clear move against shale gas extraction in ...
(Date:9/16/2014)... release is available in Spanish . ... mitosis. The study published in the Journal of Cell ... is essential for proper cell division , At this very ... This is the mechanism by which the body repairs damaged ... a fairly complex process known as "mitosis", during which the ...
Breaking Biology News(10 mins):CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3Unraveling cell division 2Unraveling cell division 3
... release chemicals as a warning signal to members of ... signals and take action. Research by Rice University psychologist ... Given that more than one sense is typically involved ... of fear facilitates humans, other stronger senses. Chen ...
... at the University of Connecticut have found a ... single-walled carbon nanotubes, a discovery that could have ... Increasing the luminescence efficiency of carbon nanotubes ... inject patients with microscopic nanotubes to detect tumors, ...
... available in Spanish . , The Amazon ... throughout the world,s largest tropical forest. The 30-year study, published ... that drought causes massive carbon loss in tropical forests, mainly ... forest has been helping to slow down climate change. ...
Cached Biology News:Rice psychologist explores perception of fear in human sweat 2UConn chemists find secret to increasing luminescence efficiency of carbon nanotubes 2UConn chemists find secret to increasing luminescence efficiency of carbon nanotubes 3Amazon carbon sink threatened by drought 2
Request Info...
... Tissue Array (MSTA) slides were designed to study ... from multiple species. Tissue slices from three ... which can then be treated as a single ... in situ hybridization. This format allows ...
... Pulser Xcell microbial system, 100 to ... for electroporation of bacterial and fungal ... unit, PC module for exponential decay ... cuvettes (5 each of 0.1 and ...
... (TSB), USP is a highly nutritious versatile ... use. Due to the inclusion of both ... support growth of many fastidious organisms without ... conforms to United States Pharmacopeia standards for ...
Biology Products: